KF
REGN icon

Krilogy Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

Krilogy Financial’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.82M Sell
2,443
-33
-1% -$25.3K 0.06% 235
2025
Q4 		$1.89M Buy
2,476
+385
+18% +$261K 0.06% 222
2025
Q3 		$1.35M Buy
+2,091
New +$1.18M 0.05% 265

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Krilogy Financial's REGN Position: Q1 2026 in Review

Krilogy Financial reduced its Regeneron Pharmaceuticals (REGN) stake by 1.3% in Q1 2026, selling an estimated $25.3K and leaving 2,443 shares worth $1.82M. The position accounts for 0.06% of the portfolio, ranked #235.

Krilogy Financial first reported a position in REGN in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.89M in Q4 2025. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Krilogy Financial held 2,443 shares of Regeneron Pharmaceuticals worth $1.82M as of Q1 2026.
  • Krilogy Financial sold 33 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $25.3K.
  • Regeneron Pharmaceuticals made up 0.06% of Krilogy Financial's portfolio in Q1 2026, its #235 holding.
  • Krilogy Financial first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Krilogy Financial's Regeneron Pharmaceuticals position peaked at $1.89M in Q4 2025.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Krilogy Financial's 13F filing for Q1 2026, filed 17 Apr 2026.